Oncogenic mutations in BRAF are present in up to 50% of melanomas, the most frequent being a valine to glutamic acid at position 600 (V600E), which constitutively activates the BRAF/MEK/ERK-signaling pathway, transmitting constant cell growth signals [2]. This evidence concerns the gene MAP2K7 and melanoma.